Removes 99.5 percent of the
unnecessary red cells, which offers a more pure concentration of stem
cells compared to any other product or method in the industry.

"BioE's
cord blood processing system helps Cord Blood America meet its objective of
providing the highest quality of cord blood storage for our clients," said
Matthew Schissler, co-founder and CEO. "We are committed to offering
our clients an unsurpassed level of processing and storage quality. The
BioE system does just that; one that our shareholders can revel in, and
comforts our customers."

About
BioE, Inc.

Headquartered
in St. Paul, Minn., BioE is a biomedical company that provides
enabling cord blood stem cell tools and technologies. The Company's
proprietary PrepaCyte® CB Processing System easily and efficiently separates
stem cells from cord blood for cryopreservation and eventual transplantation in
humans. BioE's clonal, cord blood-derived Multi-Lineage Progenitor Cell™
(MLPC™) stem cell – isolated using the company's PrepaCyte cell separation
platform – can differentiate into multiple cell types and lineages and is
readily available to clinicians and researchers for therapeutic research and
drug discovery. For more information about the company, visit www.bioe.com
or contact Gayl Chrysler at (800)350-6466 (